Compare Rio Tinto (ADR) (RIO) vs 10X Genomics Inc (TXG) Price & Performance

Rio Tinto (ADR)Trade

10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Rio Tinto (ADR) vs 10X Genomics Inc — how do they compare? Rio Tinto (ADR) trades at $94.2 (market cap $151.50B), while 10X Genomics Inc trades at $80.1 (market cap $9.92B). The key difference: Rio Tinto (ADR) is far larger — about 15.3× 10X Genomics Inc's market cap, and Rio Tinto (ADR) pays a 4.99% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Rio Tinto (ADR) for 10 Days and 10X Genomics Inc for 92 Days on average.

	RIO	TXG
Market Cap	$151.50B	$9.92B
Volume	2,164,712	9,372,166
Sector	Basic Materials	Health
52-Week High	$112.04	$97.74
52-Week Low	$65.44	$11.48
Typical Hold Time	10 Days	92 Days
Enterprise Value	$164.84B	$9.44B
Dividend Yield	4.99%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Rio Tinto (ADR)

No Aura AI signal available yet.

10X Genomics Inc

10x Genomics (TXG) trades at $77.28, down 4.19% on the day, amid a bearish technical signal. The company reported revenue of $642.82M in 2025, with a net loss of $43.54M, though it has beaten EPS estimates for three consecutive quarters. Recent news highlights the launch of its Atera spatial biology platform and a patent victory, signaling innovation and market strength. Cash flow from operations improved to $136.05M in 2025, indicating better operational efficiency.

The outlook is cautiously optimistic, with strong product demand and improving margins offering upside potential. However, persistent losses, high valuation multiples, and competitive pressures present significant risks. Analyst consensus is mixed, with a $74.30 price target slightly below the current price, reflecting uncertainty about near-term profitability.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RIO

No sentiment data available yet.

TXG

4% Buy96% Sell

Avg holding period · 92 Days

Top news

Latest headlines on both assets

RIO

Fieldstone Bio joins Rio Tinto accelerator to advance biosensor tech for faster mineral exploration.Unknown · 19 hours agoBullish Deutsche Bank raises targets on UK miners amid expected copper supply squeeze in 2027Proactive Investors · 1 day agoBullish Iron ore shipments rise for BHP and Rio Tinto despite prices hitting decade lows due to weak Chinese demand.Proactive Investors · 2 days agoNeutral View details →

TXG

10x Genomics partners with Fred Hutch to advance cancer research using single cell and spatial technologies.PRNewsWire · 1 day agoBullish Five stocks drop sharply on Oct 6, led by ArriVent BioPharma after lung cancer drug trial failure.Danny Green · 2 days agoBearish View details →

About Rio Tinto (ADR)

Rio Tinto is a global mining company that produces metals and minerals including iron ore, aluminium, copper, and lithium. Its operations supply materials used in construction, manufacturing, transportation, and energy systems.

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.